Meeder Asset Management’s Myovant Sciences Ltd. MYOV Stock Holding History

Meeder Asset Management’s Portfolio MYOV Stock Details MYOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-80	Closed	-$2K	–	1717
2018 Q1	$2K	Hold	80	–	–	﹤0.01%	1413
2017 Q4	$1K	Sell	80 -133	-62%	-$1.78K	﹤0.01%	1614
2017 Q3	$3K	Sell	213 -65	-23%	-$791	﹤0.01%	1404
2017 Q2	$3K	Sell	278 -28	-9%	-$347	﹤0.01%	1349
2017 Q1	$4K	Buy	+306	New	+$3.51K	﹤0.01%	1201

Other funds holding MYOV

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

NCM

NovaQuest Capital Management Raleigh, North Carolina $54.3M AUM 163.39% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Meeder Asset Management's MYOV Position: Q2 2018 in Review

Meeder Asset Management sold out of Myovant Sciences Ltd. (MYOV) in Q2 2018, closing a stake of 80 shares — an estimated $2K sold.

Meeder Asset Management first reported a position in MYOV in Q1 2017 and held it in 5 quarters. The position peaked at $4K in Q1 2017. 31 funds tracked by Wall St. Rank hold MYOV as of Q2 2018.

Meeder Asset Management reported no remaining Myovant Sciences Ltd. position as of Q2 2018 after selling out during the quarter.
Meeder Asset Management sold 80 Myovant Sciences Ltd. shares in Q2 2018, an estimated $2K.
Meeder Asset Management first reported a position in Myovant Sciences Ltd. in Q1 2017 and held it in 5 quarters.
Meeder Asset Management's Myovant Sciences Ltd. position peaked at $4K in Q1 2017.
31 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q2 2018.

Based on Meeder Asset Management's 13F filing for Q2 2018, filed 24 Jul 2018.